Quinolone Veterinary Drug Residue Testing: Analytes, Methods, and Regulatory Compliance

Quinolone veterinary drug residue testing is an essential food safety control that verifies whether animal-derived products comply with maximum residue limits (MRLs) for fluoroquinolones such as enrofloxacin, ciprofloxacin, danofloxacin, and marbofloxacin. Using highly sensitive techniques such as LC-MS/MS, accredited third-party laboratories can detect quinolone residues at sub-microgram-per-kilogram levels in meat, milk, eggs, honey, and aquatic products, ensuring regulatory compliance under GB 31650, EU Regulation (EU) No 37/2010, and Codex Alimentarius requirements.

Technical Overview

Quinolones are a family of synthetic broad-spectrum antibacterial agents built on a 4-quinolone nucleus. First-generation compounds such as nalidixic acid, oxolinic acid, and flumequine were followed by the fluorinated derivatives (fluoroquinolones), including enrofloxacin, ciprofloxacin, danofloxacin, difloxacin, sarafloxacin, marbofloxacin, and orbifloxacin, which rank among the most widely used veterinary antimicrobials in livestock, poultry, aquaculture, and beekeeping. These drugs act by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, thereby blocking DNA replication.

Because quinolones are well absorbed, widely distributed into tissues, and eliminated with relatively long half-lives, inappropriate dosing or failure to observe withdrawal periods leads to residues in edible tissues, milk, eggs, and honey. Chronic human exposure to low-level residues is a public health concern due to the development and dissemination of antimicrobial-resistant bacteria, potential hypersensitivity reactions, and possible effects on cartilage development. Consequently, authorities including Codex Alimentarius, the European Union, China, Japan, and the United States have established MRLs or tolerances for quinolones in food of animal origin, making routine analytical monitoring indispensable.

Testing Samples

Animal Tissues (Meat and Offal)

Skeletal muscle, liver, kidney, and fat (or skin with fat) from bovine, porcine, ovine, and caprine animals, as well as poultry such as chicken, duck, and turkey, and rabbit. Liver and kidney are priority matrices because quinolones accumulate preferentially in these organs. A typical laboratory requirement is 50–200 g of homogenized tissue, transported frozen under an unbroken cold chain.

Milk and Dairy Products

Raw milk, pasteurized and UHT milk, milk powder, cream, yogurt, and cheese. Quinolone residues are relatively thermostable and can persist through processing, with concentration effects observed in cheese curd. Sampling is usually 10–50 mL or the equivalent mass for solid dairy products.

Eggs and Egg Products

Whole egg, egg white, egg yolk, liquid egg, and dried egg powder. Fluoroquinolones deposit in yolk during the laying cycle, so residues may persist for extended periods after treatment of laying hens.

Aquatic Products

Muscle (with or without skin depending on the applicable regulation) from farmed fish such as carp, tilapia, trout, salmon, eel, and pangasius, as well as shrimp and crustaceans. Aquaculture is a major application area for quinolones, making these matrices high-priority for monitoring programs.

Honey and Bee Products

Honey, royal jelly, and lyophilized royal jelly. The high sugar content and complex matrix of honey require dedicated extraction and cleanup procedures to achieve reliable quantification.

Feed, Water, and Biological Specimens

Compound feed, premixes, and drinking water are tested to control contamination and verify medication practices. Bovine and porcine urine, serum, and plasma are used for on-farm live-animal screening prior to slaughter.

Testing Items

Residue testing typically covers a multi-analyte panel of first-generation quinolones and fluoroquinolones. Common target compounds include:

• Enrofloxacin and its active metabolite ciprofloxacin (regulated as the sum of both)
• Danofloxacin and difloxacin
• Sarafloxacin and marbofloxacin
• Orbifloxacin
• Oxolinic acid, flumequine, and nalidixic acid
• Norfloxacin, ofloxacin, levofloxacin, pefloxacin, lomefloxacin, and sparfloxacin
• Pipemidic acid and piromidic acid (legacy quinolones still monitored in some markets)

MRLs vary by compound, species, and matrix, and reference the target tissue defined in each regulation. Representative limits include:

• Enrofloxacin (sum with ciprofloxacin): commonly 100 μg/kg in bovine and poultry muscle and 100 μg/kg in bovine milk under both Chinese and EU regulations, with higher limits typically applied to liver and kidney.
• Marbofloxacin: approximately 150 μg/kg in bovine muscle and 75 μg/kg in milk under EU Regulation (EU) No 37/2010.
• Danofloxacin: milk MRLs are among the strictest, in the range of 30–100 μg/kg depending on the jurisdiction.
• Compounds without a specific MRL may fall under default limits, such as the 0.01 mg/kg uniform standard of Japan's Positive List System.

Testing Methods

Sample Preparation

Homogenized samples are extracted with acidified acetonitrile or acetonitrile combined with an EDTA-containing buffer. The addition of EDTA is important because quinolones chelate metal ions and bind to tissue proteins, and EDTA liberates the bound residues. Cleanup is performed using solid-phase extraction (SPE) with polymeric HLB or mixed-mode cation-exchange cartridges, dispersive SPE, or QuEChERS-based protocols. Honey samples are dissolved in water or dilute acid before SPE enrichment. Isotopically labeled internal standards, such as enrofloxacin-d5 and ciprofloxacin-d8, are added at the beginning of extraction to compensate for matrix effects and recovery losses.

LC-MS/MS Confirmation

Liquid chromatography coupled with tandem mass spectrometry is the internationally recognized confirmatory technique for quinolone residues, as specified in national standards such as GB/T 21312 for foods of animal origin. Separation uses reversed-phase C18 columns with water and acetonitrile mobile phases containing formic acid or ammonium acetate, and detection uses electrospray ionization in positive mode with multiple reaction monitoring (MRM). At least two ion transitions per analyte are acquired to satisfy the identification-point criteria of Commission Implementing Regulation (EU) 2021/808. Typical limits of quantification reach 0.1–1 μg/kg or lower, enabling simultaneous quantification of 10–30 quinolones in a single run.

HPLC with Fluorescence or Diode-Array Detection

High-performance liquid chromatography with fluorescence detection (HPLC-FLD) or UV/DAD detection offers a lower-cost alternative for laboratories without mass spectrometers. Because most fluoroquinolones are intrinsically fluorescent, FLD provides good sensitivity at the low μg/kg level, although the scope is generally limited to fewer analytes per injection and specificity is inferior to MS/MS.

Rapid Screening Methods

Enzyme-linked immunosorbent assays (ELISA) and lateral-flow immunochromatographic strips enable high-throughput or on-site screening of quinolone groups within minutes to hours. Commercial microbial inhibition tests provide a nonspecific screen for antibacterial activity in tissues and milk. Biosensor and fluorescence-based nanoparticle methods are emerging as additional rapid tools. All presumptive positive screening results must be confirmed by LC-MS/MS before regulatory or commercial action is taken.

Method Validation and Quality Assurance

Validated methods must demonstrate specificity, linearity (typically R² ≥ 0.99), recoveries within approximately 70–120%, and repeatability and reproducibility precision with RSD generally below 20%. Quantification employs matrix-matched calibration or isotope dilution. Confirmatory methods are evaluated through the decision limit (CCα) and detection capability (CCβ) concept, and testing should be performed by laboratories accredited to ISO/IEC 17025 with regular participation in proficiency testing schemes.

Applications

Quinolone residue testing supports multiple stakeholders across the food supply chain:

• National residue control plans and government surveillance programs targeting priority food-animal species and products.
• Import and export compliance testing to prevent border rejections and notifications under rapid alert systems.
• Supplier verification and HACCP programs operated by food processors, dairy plants, and retailers.
• On-farm medication management, including verification of withdrawal periods before milk collection or slaughter.
• Aquaculture and apiculture quality assurance for farmed fish, shrimp, and honey destined for domestic or international markets.
• Research applications such as pharmacokinetic and depletion studies, processing stability studies, and dietary exposure risk assessment.

FAQ

Why are quinolone residues so strictly regulated?

Quinolones are classified as critically important antimicrobials for human medicine. Residue exposure contributes to antimicrobial resistance and may cause hypersensitivity or other adverse effects, so regulators impose strict MRLs and monitor compliance intensively.

What detection limits can be achieved?

LC-MS/MS methods typically achieve limits of quantification of 0.1–1 μg/kg in muscle, milk, eggs, and aquatic products, comfortably below most regulatory MRLs. Rapid screening assays generally detect at or below the regulatory threshold for their target group.

How much sample is required and how should it be shipped?

For tissues and aquatic products, 50–200 g is typical; milk and eggs usually require 10–50 mL or grams. Samples should be shipped frozen with gel packs under an unbroken cold chain and protected from repeated freeze–thaw cycles.

Which regulations apply to quinolone residues?

Key frameworks include GB 31650 in China, Regulation (EU) No 37/2010 in the European Union, Codex Alimentarius MRLs (CX/MRL 2), and Japan's Positive List System. The applicable MRL depends on the destination market, compound, species, and matrix.

What is the typical turnaround time?

Confirmatory LC-MS/MS testing by accredited third-party laboratories generally takes 5–10 working days from sample receipt, depending on sample load and whether screening plus confirmation is required.

Can processed foods and honey be tested?

Yes. Validated methods exist for dairy products, egg products, and honey, although these matrices require specialized extraction and cleanup to control interferences and achieve the required sensitivity.